C07D 493/00
Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in
Official title: Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
C07D493/00 (Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in) appears on 5,389 US grants and 4,739 published applications in this corpus.
Search patents in C07D- Granted patents
- 5,389
- Published applications
- 4,739
- Assignees
- 2,131
- Inventors
- 14,097
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 42 | 0 |
| 1977 | 37 | 0 |
| 1978 | 85 | 0 |
| 1979 | 53 | 0 |
| 1980 | 81 | 0 |
| 1981 | 76 | 0 |
| 1982 | 51 | 0 |
| 1983 | 43 | 0 |
| 1984 | 60 | 0 |
| 1985 | 75 | 0 |
| 1986 | 66 | 0 |
| 1987 | 84 | 0 |
| 1988 | 49 | 0 |
| 1989 | 78 | 0 |
| 1990 | 66 | 0 |
| 1991 | 89 | 0 |
| 1992 | 97 | 0 |
| 1993 | 89 | 0 |
| 1994 | 80 | 0 |
| 1995 | 96 | 0 |
| 1996 | 67 | 0 |
| 1997 | 103 | 0 |
| 1998 | 102 | 0 |
| 1999 | 81 | 0 |
| 2000 | 105 | 0 |
| 2001 | 117 | 18 |
| 2002 | 106 | 105 |
| 2003 | 119 | 176 |
| 2004 | 94 | 176 |
| 2005 | 72 | 146 |
| 2006 | 95 | 144 |
| 2007 | 78 | 124 |
| 2008 | 74 | 161 |
| 2009 | 97 | 183 |
| 2010 | 123 | 190 |
| 2011 | 116 | 208 |
| 2012 | 157 | 212 |
| 2013 | 190 | 205 |
| 2014 | 170 | 227 |
| 2015 | 205 | 276 |
| 2016 | 218 | 255 |
| 2017 | 228 | 228 |
| 2018 | 178 | 216 |
| 2019 | 213 | 219 |
| 2020 | 174 | 198 |
| 2021 | 127 | 197 |
| 2022 | 133 | 205 |
| 2023 | 118 | 225 |
| 2024 | 128 | 178 |
| 2025 | 122 | 167 |
| 2026 | 82 | 100 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- 2-aminopyrimidine compound and pharmaceutical composition thereof and application thereof6 Oct 2026US 12,753,185 B2Guangzhou Salustier Biosciences Co., Ltd.
- Compound and composition for preventing or treating neuroinflammatory brain diseases comprising same as active ingredient6 Oct 2026US 12,753,186 B2Korea Institute of Ocean Science & Technology
- Control of pyrolysis conditions and feedstock for the production of desirable compounds6 Oct 2026US 12,753,346 B1Talipot Cool Extract (IP), LLC
- Organic molecules for use in light-emitting devices29 Sep 2026US 12,747,210 B2Samsung Display Co., Ltd.
- Fibroblast activation protein ligands for targeted delivery applications29 Sep 2026US 12,747,224 B2Philochem AG
- Compounds Targeting STAT3 for Use in Treating Pancreatic Cancer8 Oct 2026US 2026/0308169 A1Board of Regents, The University of Texas System
- Organic compound, light-emitting device, light-emitting apparatus, electronic device, display device, lighting device8 Oct 2026US 2026/0314255 A1Semiconductor Energy Laboratory Co.Ltd.
- Ascorbic acid derivatives and cosmetic thereof1 Oct 2026US 2026/0294769 A1Seiwa Kasei Company, Limited
- Compounds for treating cancer1 Oct 2026US 2026/0297066 A1Genesis Molecular AI, Inc.
- Oxazole trpml1 agonists and uses thereof1 Oct 2026US 2026/0297104 A1Libra Therapeutics, Inc.
Most cited
By later US patents
- Bicyclonucleoside and oligonucleotide analogues547US 6,268,490 B1Takeshi Imanishi · 2001
- Precursor to nucleic acid probe282US 4,754,065 ACetus Corporation · 1988
- Pyrazole derivatives, method of preparing them and pharmaceutical compositions in which they are present215US 5,624,941 ASanofi · 1997
- Novel ether substituted fluorescein polyamino acid compounds as fluorescers and quenchers186US 4,318,846 ASyva Company · 1982
- Process for labeling nucleic acids using psoralen derivatives180US 4,582,789 ACetus Corporation · 1986